219 related articles for article (PubMed ID: 27161997)
21. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
22. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
[TBL] [Abstract][Full Text] [Related]
23. A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa.
Biggerstaff M; Cohen C; Reed C; Tempia S; McMorrow ML; Walaza S; Moyes J; Treurnicht FK; Cohen AL; Hutchinson P; Stoecker C; Steinberg J
Vaccine; 2019 Oct; 37(46):6874-6884. PubMed ID: 31575494
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
Meier G; Gregg M; Poulsen Nautrup B
J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
[TBL] [Abstract][Full Text] [Related]
25. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
[TBL] [Abstract][Full Text] [Related]
26. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
[TBL] [Abstract][Full Text] [Related]
27. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee Technical Working Group
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
[TBL] [Abstract][Full Text] [Related]
29. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1333-1349. PubMed ID: 31838802
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
32. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
33. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
34. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
Mennini FS; Bini C; Marcellusi A; Rinaldi A; Franco E
Hum Vaccin Immunother; 2018; 14(8):1867-1873. PubMed ID: 29708843
[TBL] [Abstract][Full Text] [Related]
36. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
de Boer PT; Backer JA; van Hoek AJ; Wallinga J
BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
[TBL] [Abstract][Full Text] [Related]
37. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
Naber SK; Bruijning-Verhagen PCJL; de Hoog MLA; van Giessen A
Vaccine; 2020 Apr; 38(17):3387-3396. PubMed ID: 32115297
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness analysis of elementary school-located vaccination against influenza--results from a randomized controlled trial.
Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
Vaccine; 2013 Apr; 31(17):2156-64. PubMed ID: 23499607
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of influenza vaccination during pregnancy.
Chaiken SR; Hersh AR; Zimmermann MS; Ameel BM; Layoun VR; Caughey AB
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5244-5252. PubMed ID: 33478281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
